Andrew Briggs
Andrew Briggs
Verified email at
TitleCited byYear
Decision modelling for health economic evaluation
A Briggs, M Sculpher, K Claxton
OUP Oxford, 2006
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre …
GJ Peek, M Mugford, R Tiruvoipati, A Wilson, E Allen, MM Thalanany, ...
The Lancet 374 (9698), 1351-1363, 2009
Consolidated health economic evaluation reporting standards (CHEERS) statement
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
Cost Effectiveness and Resource Allocation 11 (1), 6, 2013
An introduction to Markov modelling for economic evaluation
A Briggs, M Sculpher
Pharmacoeconomics 13 (4), 397-409, 1998
Handling uncertainty in cost-effectiveness models
AH Briggs
Pharmacoeconomics 17 (5), 479-500, 2000
Pulling cost‐effectiveness analysis up by its bootstraps: a non‐parametric approach to confidence interval estimation
AH Briggs, DE Wonderling, CZ Mooney
Health economics 6 (4), 327-340, 1997
Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good …
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
Value in Health 16 (2), 231-250, 2013
Cost‐effectiveness acceptability curves–facts, fallacies and frequently asked questions
E Fenwick, BJ O'Brien, A Briggs
Health economics 13 (5), 405-415, 2004
Economic evaluation in clinical trials
HA Glick, JA Doshi, SS Sonnad, D Polsky
OUP Oxford, 2014
Modeling good research practices—overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–1
JJ Caro, AH Briggs, U Siebert, KM Kuntz
Medical Decision Making 32 (5), 667-677, 2012
Good research practices for cost‐effectiveness analysis alongside clinical trials: the ISPOR RCT‐CEA task force report
S Ramsey, R Willke, A Briggs, R Brown, M Buxton, A Chawla, J Cook, ...
Value in health 8 (5), 521-533, 2005
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ...
Diabetologia 47 (10), 1747-1759, 2004
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
A Briggs, M Sculpher, M Buxton
Health economics 3 (2), 95-104, 1994
Confidence intervals or surfaces? Uncertainty on the cost‐effectiveness plane
A Briggs, P Fenn
Health economics 7 (8), 723-740, 1998
The death of cost‐minimization analysis?
AH Briggs, BJ O'Brien
Health economics 10 (2), 179-184, 2001
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis
JS Hoch, AH Briggs, AR Willan
Health economics 11 (5), 415-430, 2002
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
K Claxton, M Sculpher, C McCabe, A Briggs, R Akehurst, M Buxton, ...
Health economics 14 (4), 339-347, 2005
Handling uncertainty when performing economic evaluation of healthcare interventions
AH Briggs, AM Gray
Health Technol Assess 3 (2), 1-134, 1999
Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease
AH Briggs, R Goeree, G Blackhouse, BJ O’Brien
Medical decision making 22 (4), 290-308, 2002
Review of statistical methods for analysing healthcare resources and costs
B Mihaylova, A Briggs, A O'Hagan, SG Thompson
Health economics 20 (8), 897-916, 2011
The system can't perform the operation now. Try again later.
Articles 1–20